The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB
- PMID: 8800208
- DOI: 10.1006/jmbi.1996.0485
The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB
Abstract
Since the first report documenting that HIV-1 Vpr was involved in the stimulation of transactivation of several unrelated promoters, little additional information has been reported. By using transient transfection experiments, we confirmed and extended these previously reported data. Further in vivo experiments showed that Vpr can co-operatively stimulate transactivation activity of a minimal promoter containing one GAL4 DNA-binding site, when it is co-expressed with different heterologous activator domains fused to GAL4 DNA-binding domain. Thus, Vpr could transactivate in concert with an activator domain, but has no effect on the transactivation of a minimal promoter in the absence of activator protein. To investigate whether Vpr can interact with components of the basal transcriptional machinery, in vitro protein-protein binding assays were performed using either translated, radiolabeled Vpr or TFIIB proteins and glutathione S-transferase Vpr or TFIIB chimeric proteins. We demonstrated that the portion of Vpr ranging from amino acids 15 to 77 interacts specifically with the basal transcription factor TFIIB. Also, our data indicated that the N-terminal domain of TFIIB is required for the interaction.
Similar articles
-
B-MYB transactivates its own promoter through SP1-binding sites.Oncogene. 1999 Feb 11;18(6):1333-9. doi: 10.1038/sj.onc.1202421. Oncogene. 1999. PMID: 10022815
-
Interaction between an acidic activator and transcription factor TFIIB is required for transcriptional activation.Nature. 1993 Jun 24;363(6431):741-4. doi: 10.1038/363741a0. Nature. 1993. PMID: 8515819
-
Recruitment of TBP or TFIIB to a promoter proximal position leads to stimulation of RNA polymerase II transcription without activator proteins both in vivo and in vitro.Biochem Biophys Res Commun. 1999 Mar 5;256(1):45-51. doi: 10.1006/bbrc.1999.0280. Biochem Biophys Res Commun. 1999. PMID: 10066420
-
Partner molecules of accessory protein Vpr of the human immunodeficiency virus type 1.DNA Cell Biol. 2004 Apr;23(4):193-205. doi: 10.1089/104454904773819789. DNA Cell Biol. 2004. PMID: 15142377 Review.
-
Cellular and viral transcriptional activators.Harvey Lect. 1992-1993;88:67-96. Harvey Lect. 1992. PMID: 1365875 Review. No abstract available.
Cited by
-
The HIV-1 protein Vpr targets the endoribonuclease Dicer for proteasomal degradation to boost macrophage infection.Virology. 2013 Sep;444(1-2):191-202. doi: 10.1016/j.virol.2013.06.010. Epub 2013 Jul 9. Virology. 2013. PMID: 23849790 Free PMC article.
-
Regulation of HIV-1 transcription.Gene Expr. 1999;8(2):67-84. Gene Expr. 1999. PMID: 10551796 Free PMC article. Review.
-
Human immunodeficiency virus type 1 induction mediated by genistein is linked to cell cycle arrest in G2.J Virol. 1998 Oct;72(10):8174-80. doi: 10.1128/JVI.72.10.8174-8180.1998. J Virol. 1998. PMID: 9733859 Free PMC article.
-
Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor.J Virol. 1997 Dec;71(12):9358-65. doi: 10.1128/JVI.71.12.9358-9365.1997. J Virol. 1997. PMID: 9371595 Free PMC article.
-
HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention.Retrovirology. 2011 Apr 13;8:25. doi: 10.1186/1742-4690-8-25. Retrovirology. 2011. PMID: 21489275 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases